GeoVax Labs, Inc.
GOVX· Nasdaq
GOVXGeoVax Labs, Inc.
Filed Jul 27, 2026 · 10-Q · 27 days after period end · 0001437749-26-024523
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $852.28K | $300.68K | $0.00 |
| Net Income | -$4.43M | -$5.37M | -$5.06M | -$5.93M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeoVax Labs, Inc. · CIK 832489 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Jul 27, 2026 · 27 d after period end
